Le Lézard
Classified in: Health, Science and technology
Subject: PDT

FDA Clears nView Medical's First Imaging System, nView s1


SALT LAKE CITY, July 13, 2019 /PRNewswire-PRWeb/ -- nView medical Inc. (nView) today announced the U.S. Food and Drug Administration (FDA) clearance of nView s1, the company's first imaging system, bringing breakthrough imaging technology to surgery.

nView's mission is to make surgery safer, faster, and consistently accurate by creating instant 3D information throughout the surgical procedure. nView s1 integrates the latest developments in low-dose x-ray imaging with intelligent imaging algorithms to provide fluoroscopic and multiplanar views derived from tomographic reconstructions. These views can be used by surgeons to accurately assess the anatomy and placement of implants during spinal and orthopedic procedures.

"nView s1 is an imaging platform that provides invaluable information to surgeons throughout the procedure. The technology can be used intraoperatively to visualize the surgery and at the end of the procedure to confirm the quality of the surgery. The future of surgery will be enabled by automation and quantification. nView s1 is our first step in that direction" said Cristian Atria, founder and CEO at nView medical.

Lisa Last, COO, commented: "nView s1 has been cleared as a fluoroscopic and tomographic imaging system for adult and pediatric populations. In pediatrics, our low-dose operation brings a unique opportunity to increase precision via 3D imaging while minimizing radiation exposure. The 510(k) clearance will allow us to expand our work with research partners in pilot sites".

About nView
nView medical, based in Salt Lake City, UT, is an early stage start-up whose mission is to make surgery safer, faster, and consistently accurate. nView develops imaging systems, bringing breakthrough AI solutions for image creation, image processing, and image visualization to surgery. nView medical backers include the National Science Foundation (NSF), the National Institutes of Health (NIH), the State Of Utah, the National Consortium for Pediatric Device Innovation, MedtechInnovator, Dr. Kevin Foley, MD, and Fusion Fund (Palo Alto, CA).

 

SOURCE nView medical


These press releases may also interest you

at 21:00
WORLD's 360/VR/Telepresence/CG Game/CG Software/Animator/3D photography & videography/Drone/Robot participants including BUSINESSes, PROFESSIONALs, ENGINEERs, CONTENT CREATORs, ... are called to join "Complete 360 Degree Directional and Spatial 3D...

at 21:00
Today, Link REIT (Hong Kong stock code 823) and Allinfra announce an agreement to collaborate on the use of blockchain technology for the tokenization of assets, commencing with a pilot solar project. This partnership represents the coming together...

at 19:50
Source Photonics, a market leader of optical transceivers for wireless applications, announces a comprehensive portfolio of 50Gb/s products serving 5G mid-haul applications. Source Photonics' product portfolio leverages 30 years of high-speed optical...

at 19:05
Celltrion Healthcare today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for CT-P13 SC for marketing authorisation in the European Union (EU) in people...

at 19:05
Source Photonics, a leading vendor of optical connectivity products for Access and Datacom applications, will demonstrate its complete 400G portfolio with industry partners at ECOC 2019 from September 23-25. Source Photonics has added a wide range...

at 16:47
Ucore Rare Metals, Inc. ("Ucore") issued a press release on September 10, 2019 (the "Press Release") in which it referenced the use of "hybrid technology" at the non-existent Alaskan Strategic Metal Complex ("SMC") and stated that the SuperLig®-One...



News published on 13 july 2019 at 16:00 and distributed by: